| pubmed-article:16778605 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16778605 | lifeskim:mentions | umls-concept:C0023903 | lld:lifeskim |
| pubmed-article:16778605 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:16778605 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:16778605 | lifeskim:mentions | umls-concept:C1096776 | lld:lifeskim |
| pubmed-article:16778605 | lifeskim:mentions | umls-concept:C0206012 | lld:lifeskim |
| pubmed-article:16778605 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:16778605 | lifeskim:mentions | umls-concept:C0166237 | lld:lifeskim |
| pubmed-article:16778605 | lifeskim:mentions | umls-concept:C0205184 | lld:lifeskim |
| pubmed-article:16778605 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16778605 | pubmed:dateCreated | 2006-6-16 | lld:pubmed |
| pubmed-article:16778605 | pubmed:abstractText | In our multi center trial we compared the potentials of biphasic contrast-enhanced computed tomography (CT) and a novel tissue-specific magnetic resonance imaging (MRI) contrast agent gadoxetic acid disodium in liver lesion characterization. | lld:pubmed |
| pubmed-article:16778605 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16778605 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16778605 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16778605 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16778605 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16778605 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16778605 | pubmed:issn | 0363-8715 | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:StolpenAlan... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:GrazioliLuigi... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:JungGregorG | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:BellinMarie-F... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:AyusoCarmenC | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:KrauseDenisD | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:PretoriusE... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:LaghiAndreaA | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:LeenEdwardE | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:BlomqvistLenn... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:ReinholdCarol... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:HammerstinglR... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:BalzerThomasT | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:HalavaaraJuha... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:CarterRickR | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:StiskalMichae... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:HuppertzAlexa... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:BreuerJosyJ | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:MartinJulioJ | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:LupatelliLuci... | lld:pubmed |
| pubmed-article:16778605 | pubmed:author | pubmed-author:MarsiliLucaL | lld:pubmed |
| pubmed-article:16778605 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16778605 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:16778605 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16778605 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16778605 | pubmed:pagination | 345-54 | lld:pubmed |
| pubmed-article:16778605 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16778605 | pubmed:meshHeading | pubmed-meshheading:16778605... | lld:pubmed |
| pubmed-article:16778605 | pubmed:meshHeading | pubmed-meshheading:16778605... | lld:pubmed |
| pubmed-article:16778605 | pubmed:meshHeading | pubmed-meshheading:16778605... | lld:pubmed |
| pubmed-article:16778605 | pubmed:meshHeading | pubmed-meshheading:16778605... | lld:pubmed |
| pubmed-article:16778605 | pubmed:meshHeading | pubmed-meshheading:16778605... | lld:pubmed |
| pubmed-article:16778605 | pubmed:meshHeading | pubmed-meshheading:16778605... | lld:pubmed |
| pubmed-article:16778605 | pubmed:articleTitle | Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial. | lld:pubmed |
| pubmed-article:16778605 | pubmed:affiliation | Jorvi Hospital, Department of Radiology, Espoo, Finland. juha.halavaara@hus.fi | lld:pubmed |
| pubmed-article:16778605 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16778605 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16778605 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16778605 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16778605 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16778605 | lld:pubmed |
